This grand round has already taken place.
Genetic perturbation is a powerful way to analyze the function of proteins in vivo. For this purpose, we pioneered to develop the auxin-inducible degron (AID) technology (Nishimura et al, Nat. Meth., 2009). By combining with CRISPR-based genome editing, it is now possible to generate AID conditional mutants of human cells (Natsume et al., Cell Reports, 2016; Yesbolatova et al. Methods, 2019). I would like to share the history as well as our recent improvements.
Dates and Times
Start: 10/21/2019 12:00 PM
End: 10/21/2019 1:00 PM
1) To give an introduction on the history, concepts and methods of the auxin-inducible degron (AID) technology.
2) To discuss recent improvements in auxin-inducible degron (AID) technology.
3) To review auxin-inducible degron (AID) technology .
Pharmacology conference room BST level 8 R180
100 Nicolls Rd
R180, BST L8
Stony Brook, NY 11794
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.